PropertyValue
?:definition
  • An orally bioavailable micro-immunotherapeutic agent composed of various immune substances in diluted doses, with potential immunomodulating, anti-infective and anti-viral activities. The micro-immunotherapeutic agent 2LXFS contains various recombinant immunological active ingredients in low concentrations, including, but not limited to, cytokines, such as interleukin-1 (IL-1), IL-2, interferon alpha (IFN-a), IFN gamma (IFN-g), tumor necrosis factor alpha (TNF-a), and specific nucleic acids (SNAs) that are small synthesized oligonucleotides that prevent gene expression, such as the genes involved in viral replication. Upon oral administration of micro-immunotherapeutic agent 2LXFS, the active ingredients may help balance, restore and/or modulate the immune system. This may restore an adequate, re-adjusted anti-antiviral immune response. The formulation within each capsule is different and the levels of concentration of each substance can vary to allow stimulation, modulation and/or inhibition of the immune response in order to mimic what would naturally occur within the body. Therefore, the capsules are administered in a specific order.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5447423_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5447423_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all